CME

CME


TROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use

November 15, 2022

Host: Benjamin Levy, MD Guest: Rebecca Heist, MD, MPH Guest: Peter Bela Illei, MD Antibody-drug conjugates (ADCs) have promising clinical data in the treatment of advanced non-small cell lung cancer. Listen in as Drs. Benjamin Levy, Rebecca Heist